- Home
- NKTR vs CCU Comparison
NKTR vs CCU Comparison
Compare NKTR & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NKTR | CCU |
|---|---|---|
| Founded | 1990 | 1850 |
| Country | United States | Chile |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.1B |
| IPO Year | 1996 | 2001 |
Fundamental Metrics
Financial Performance| Metric | NKTR | CCU |
|---|---|---|
| Price | $72.79 | $11.94 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 7 | 2 |
| Target Price | ★ $146.67 | $12.00 |
| AVG Volume (30 Days) | ★ 481.5K | 130.8K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.90% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $307,711,000.00 | N/A |
| Revenue This Year | N/A | $7.42 |
| Revenue Next Year | N/A | $4.71 |
| P/E Ratio | ★ N/A | $18.35 |
| Revenue Growth | ★ 86.00 | N/A |
| 52 Week Low | $33.40 | $10.71 |
| 52 Week High | $109.00 | $15.36 |
Technical Indicators
Market Signals| Indicator | NKTR | CCU |
|---|---|---|
| Relative Strength Index (RSI) | 49.04 | 50.88 |
| Support Level | $70.24 | $11.40 |
| Resistance Level | $76.49 | $12.13 |
| Average True Range (ATR) | 2.86 | 0.37 |
| MACD | -0.17 | -0.04 |
| Stochastic Oscillator | 36.36 | 38.83 |
Price Performance
Historical ComparisonAbout NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.